MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2023 International Congress

August 27-31, 2023. Copenhagen, Denmark.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Use of insect model to study Parkinson’s disease pathophysiology by inducing GSH-depletion and behavioral deficits among larvae: Evidences of ameliorative properties of phytoconstituents

    G. Chandran, R. D'Silva, M. Muralidhara (MYSURU, India)

  • Use of levodopa-carbidopa intestinal gel to treat a patient with multiple system atrophy (MSA)

    A. Ferreira, S. Marques, A. Vieira, M. Coelho, G. Carneiro, M. Rodrigues (Braga, Portugal)

  • Use of stimview technology in deep brain stimulation of Parkinson´s disease patients

    A. Rodríguez-Sanz, S. Serrano López, B. Mansilla, M. Román, JF. Paz (Madrid, Spain)

  • Use of the Dysphagia Handicap Index (DHI) patient reported outcomes measure in Parkinson disease and cervical dystonia

    A. Silbergleit (Birmingham, USA)

  • User Experience (UX): Successful Remote Engagement Strategy for Individuals at Risk for Parkinson’s Disease in PPMI

    L. Lemon, R. Dobkin, M. Kuhl, K. Fabrizio, C. Stanley, L. Heathers, C. Hobbick, B. Mcmahon, M. Totten, K. Marek (New Haven, USA)

  • using latent class mixed modelling to profile Parkinson’s disease patients at risk of cognitive decline

    D. Pourzinal, R. Lawson, A. Yarnall, D. Burn, C. Williams-Gray, R. Barker, J. Yang, K. Mcmahon, J. O'Sullivan, G. Byrne, N. Dissanayaka (Herston, Australia)

  • Using Long read sequencing to identify complex structural variants in PRKN-PD

    K. Daida, M. Funayama, A. Miano-Burkhardt, L. Mailik, K. Billingsley, M. Ishiguro, H. Yoshino, K. Ogaki, G. Oyama, R. Nonaka, W. Akamatsu, C. Blauwendraat, N. Hattori (Bethesda, USA)

  • Using mediation analysis to account for the effect of Parkinson’s Disease medications on disease progression

    T. Liu, W. Lu, M. Yang, Y. Zhu, T. Dam, W. Hirst (Cambridge, USA)

  • Using wearable wireless technology to understand the natural history of adrenomyeloneuropathy in both clinic and home settings: 1-year follow-up in the CYGNET study

    C. Bergner, W. Koehler, J. Bonkowsky, C. Stephen, F. Eichler, L. Glenn, M. Engelen (Leipzig, Germany)

  • Utility and safety of same day discharge after Deep Brain Stimulator Electrode Implantation: a feasibility study

    S. Pardakhtim, M. Marsans, S. Srivastal, J. Roberts, F. Farrokhi (Seattle, USA)

  • « Previous Page
  • 1
  • …
  • 178
  • 179
  • 180
  • 181
  • 182
  • …
  • 186
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley